Newsroom

Newsroom

MultiOmyx 101: An Introduction to Multiplexing Technology

Blog
Read More

Comprehensive Genomic Profiling (CGP) expands precision medicine’s utility

Blog
Read More

NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer

Press Release
Read More

NeoGenomics will be exhibiting at the 2022 ASCO Annual Meeting from June 4 – 6

Blog
Read More

NeoGenomics Receives CAP Certification in their Suzhou China Pharma Services Laboratory

Press Release
Read More

NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences

Press Release
Read More

NeoGenomics Appoints Lynn Tetrault Interim CEO

Press Release
Read More

NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Present New Data Further Validating the Application of its RaDaR® MRD and InVisionFirst®-Lung Tests at the 2022 ASCO Annual Meeting

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients